SB Investment Advisers Sells $17M Worth of Vir Biotechnology Shares
On May 15, 2026, SB Investment Advisers (UK) Ltd reported selling nearly 2.17 million shares in Vir Biotechnology for an estimated $17.28 million during the first quarter of 2026. Despite this reduction, Vir's stock has risen by 93% over the past year and currently trades at $8.79 per share.
Tickers: $VIR
Topics: biotech investment activity stock trading